<DOC>
<DOCNO>
EP-0006724
</DOCNO>
<TEXT>
<DATE>
19800109
</DATE>
<IPC-CLASSIFICATIONS>
A61K-9/02 A61K-47/00 A61K-9/06 <main>A61K-9/02</main> A61K-9/00 A61K-9/16 A61K-9/18 A61K-47/48 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical compositions containing urea.
</TITLE>
<APPLICANT>
phares pharm res nvnl<sep>phares pharma res nv<sep>phares pharmaceutical research n.v.john b. gorsiraweg no 6 p.o. box 889curacao netherlands antillesan<sep>phares pharmaceutical research n.v.  <sep>
</APPLICANT>
<INVENTOR>
ayres peter james<sep>leigh steven<sep>ayres, peter james<sep>leigh, steven<sep>ayres, peter jamesp.o. box 191norwich, new york 13815us<sep>leigh, steven2 mansfield roadsouth croydon, surreygb<sep>ayres, peter james<sep>leigh, steven<sep>ayres, peter jamesp.o. box 191norwich, new york 13815us<sep>leigh, steven2 mansfield roadsouth croydon, surreygb<sep>
</INVENTOR>
<ABSTRACT>
pharmaceutical compositions for application topically or by  suppository comprise:   a) a medicament, preferably protected from degradation by  moisture by being presented in small particles of a waxy mateÂ­ rial,   b) from 5% to 40% of an inclusion compound of urea with a  straigt-chain aliphatic compound, preferably a fatty acid or  alcohol,   c) up to 50% of an inert insoluble powder such as starch.    d) from 25% to 90% of an inert carrier, components a), b)  and c) being dispersed in d).  the compositions have good storage stability and a  smooth texture.  
</ABSTRACT>
</TEXT>
</DOC>
